Clinical Study

Bronchoalveolar Activation of Coagulation and Inhibition of Fibrinolysis during Ventilator-Associated Lung Injury

Figure 3

Systemic levels of coagulation and fibrinolysis. Thrombin-antithrombin (TATc) and plasminogen activator activity (PAA) in patients who developed VALI (closed symbols, ), and patients who did not develop VALI (open symbols, ). Data are medians ± IQR. *, .
961784.fig.003a
(a)
961784.fig.003b
(b)